Has Suresh Nair, MD received payments from drug or device companies?

Yes. Drug and device makers reported $19,704 in general payments to Suresh Nair, MD across 1,062 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Suresh Nair, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Suresh Nair, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Suresh Nair, MD

Internal Medicine · Louisville, KYNPI 1629002787

Payments from drug & device makers

$19,704in general payments, 2019–2025

Across 1,062 payments — averaging $18.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$2K
AbbVie$2K
Mimedx Group, Inc.$2K
Pfizer$1K
Vanda Pharmaceuticals Inc.$1K
UCB, Inc.$1K
plus $11K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	42	$1,981
AbbVie(2 entities)	106	$1,618
Mimedx Group, Inc.	25	$1,577
Pfizer	107	$1,433
Vanda Pharmaceuticals Inc.	51	$1,104
UCB, Inc.	59	$1,070
Otsuka America Pharmaceutical, Inc.	60	$853
Novo Nordisk	37	$711
Novartis	43	$703
Boehringer Ingelheim	51	$639
Esperion Therapeutics, Inc.	35	$548
Amgen	39	$545
Bayer	34	$508
Johnson & Johnson	36	$480
GSK	32	$457
Philips North America LLC	5	$370
Merck	21	$337
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	20	$317
Lilly USA, LLC	22	$313
Medtronic(2 entities)	12	$310
Sanofi-aventis U.S. LLC	18	$309
Avanir Pharmaceuticals, Inc.	21	$283
Corium, LLC	13	$244
Astellas Pharma US Inc	12	$218
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	13	$207
Phathom Pharmaceuticals, Inc.	5	$199
Exact Sciences	9	$179
Sunovion Pharmaceuticals Inc.	11	$161
Biohaven Pharmaceutical Holding Company Ltd.	11	$156
Corcept Therapeutics	8	$143
Biohaven Pharmaceuticals, Inc.	7	$131
Urgo Medical North America, LLC	5	$125
Pacira Therapeutics, Inc.	8	$110
Amarin Pharma, Inc.	8	$109
Impel Pharmaceuticals Inc.	5	$97
Eisai Inc.	6	$93
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	6	$72
Mylan Specialty L.p.	4	$70
Takeda Pharmaceuticals U.S.A., Inc.	4	$61
Ardelyx, Inc.	3	$58
Convatec Inc.	3	$58
Teva Pharmaceuticals USA, Inc.	3	$48
Lundbeck LLC	2	$47
Abbott	3	$46
Dexcom, Inc.	2	$42
Organogenesis Inc.	2	$37
Averitas Pharma Inc.	2	$36
ANI Pharmaceuticals, Inc.	2	$36
Nevro Corp.	2	$35
Scpharmaceuticals Inc.	2	$34
Biogen	2	$32
Supernus Pharmaceuticals, Inc.	2	$31
Axsome Therapeutics, Inc.	2	$31
Kyowa Kirin, Inc.	1	$27
Hologic Sales And Service, LLC	2	$26
Valeritas, Inc.	2	$26
Insulet Corporation	1	$23
Ultragenyx Pharmaceutical Inc.	1	$22
Gilead	1	$21
Vertex	1	$20

How this compares

$19,704 in reported general payments places this provider in the 95th percentile of 1,284 internal medicine providers in Kentucky.

See all internal medicine providers in Kentucky →

Medicare billing

Part B allowed, 2024

$71,990

Medicare patients

293

Services billed

1,192

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Louisville

Jason ChesneyLouisville$6.3M
Robert SasserLouisville$62K
Kelley McIntyreLouisville$48K
Lal TanwaniLouisville$38K
Mark WilliamsLouisville$33K
Scott YoungLouisville$24K
Frank SimonLouisville$22K
Walter BruningLouisville$22K
Brian ParadowskiLouisville$20K
Yiyi TsaiLouisville$19K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →